HB 1250

  • Arkansas House Bill
  • 2023 Regular Session
  • Introduced in House Jan 25, 2023
  • Passed House Feb 01, 2023
  • Passed Senate Feb 09, 2023
  • Signed by Governor Feb 14, 2023

To Amend The Prescription Drug Monitoring Program Advisory Committee; And To Amend The Confidentiality Of And The Providing Of Information By The Prescription Drug Monitoring Program.

Abstract

Bill Sponsors (3)

L. Johnson

     
Primary

J. Boyd

     
Primary

Votes


Actions


Feb 14, 2023

House

Notification that HB1250 is now Act 67

Feb 09, 2023

House

Correctly enrolled and ordered transmitted to the Governor's Office.

Feb 09, 2023

House

TO BE ENROLLED

Feb 09, 2023

House

Returned From the Senate as passed.

Feb 09, 2023

Senate

Returned to the House as passed.

Feb 09, 2023

Senate

Read the third time and passed.

Feb 08, 2023

Senate

Returned by the Committee, with the recommendation that it Do Pass

Feb 01, 2023

Senate

Read first time, rules suspended, read second time, referred to PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE - SENATE

Feb 01, 2023

Senate

Received from the House.

Feb 01, 2023

House

Read the third time and passed and ordered transmitted to the Senate.

Jan 31, 2023

House

Returned by the Committee Do Pass

Jan 25, 2023

House

Read the first time, rules suspended, read the second time and referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE

Jan 25, 2023

House

Filed

Bill Text

Bill Text Versions Format
HB 1250 PDF
Act 67 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Arkansas General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.